Chief Medical Officer Summit Speakers
Iva Toudjarska, MBA, PhD
Halloran Consulting Group, Inc
Dr Iva Toudjarska joined Halloran Consulting Group in 2016. With more than 15 years of experience, she has served biopharmaceutical companies across all phases of drug discovery, development and commercialization. Dr Toudjarska’s expertise spans across diverse range of therapeutic areas with focus on oncology, immuno-oncology, neurodegenerative and orphan diseases, hematology, cardiology, gene therapy, molecular and companion diagnostics and biomarkers. At Halloran, she focuses on partnering with clients to perform in depth and timely due diligence to inform strategic decision-making.
Prior to joining Halloran, Dr Toudjarska spent 4 years as a consultant to start-ups and pharma clients. As part of Putnam Associates’ team, she informed strategic insights and decisions pertaining to new product development, portfolio prioritization, clinical development, and commercial opportunity assessments for large pharma clients. Dr Toudjarska has informed launch of new therapeutics, as well as strategic brand planning and product positioning. Previously, she was a founding employee at Alnylam Pharmaceuticals, the leader in RNAi therapeutics. During her nine year tenure at Alnylam, as part of a multi-disciplinary team, Dr Toudjarska advanced several programs to clinic, most notably ALN-RSV (a virology program) and ALN-VSP (an oncology program). She led the evaluation and initiation of two hematology programs ALN-AT3 for the treatment of hemophilia (currently in clinic) and ALN-TMP for the treatment of beta-thalassemia.
Dr Toudjarska earned a Doctor of Philosophy from Bulgarian Academy of Sciences in Molecular Genetics and Masters of Business Administration from F.W. Olin Graduate School of Business at Babson College.